News | December 08, 2008

CT Angiography Debate Heats Up Post-CORE 64

December 8, 2008 – Investigators say CORE 64 shows that CT angiography can accurately identify the presence and severity of obstructive coronary artery disease in symptomatic patients, but that it is not yet ready to replace invasive coronary angiography.

Since the researchers, a team of imaging specialists at Johns Hopkins, published the results of the international multicenter trial (CorE 64) entitled "Diagnostic Performance of Coronary Angiography by 64-Row CT," it has been a hot topic of debate throughout the medical industry.

In their conclusion, which appears in an abstract the New England Journal of Medicine (NEJM) published on November 27, 2008 (Volume 359:2324-2336, Number 22), they stated: “Multidetector CT angiography accurately identifies the presence and severity of obstructive coronary artery disease and subsequent revascularization in symptomatic patients. The negative and positive predictive values indicate that multidetector CT angiography cannot replace conventional coronary angiography at present.”

Upon publication by NEJM, the mainstream media has reported on the findings from differing angles. Some reports have emphasized how the accuracy of CT angiography could potentially eliminate many invasive angiograms, while other popular media outlets have implied that researchers doubt the utility of CT as a heart test.

The study involved 291 patients with calcium scores of 600 or less, segments 1.5-mm or more in diameter were analyzed by means of CT and conventional angiography at independent core laboratories. Stenoses of 50 percent or more were considered obstructive. The area under the receiver-operating-characteristic curve (AUC) was used to evaluate diagnostic accuracy relative to that of conventional angiography and subsequent revascularization status, whereas disease severity was assessed with the use of the modified Duke Coronary Artery Disease Index.

A total of 56 percent of patients had obstructive coronary artery disease. The patient-based diagnostic accuracy of quantitative CT angiography for detecting or ruling out stenoses of 50 percent or more according to conventional angiography revealed an AUC of 0.93 (95 percent confidence interval), with a sensitivity of 85 percent, a specificity of 90 percent, a positive predictive value of 91 percent, and a negative predictive value of 83 percent. CT angiography was similar to conventional angiography in its ability to identify patients who subsequently underwent revascularization. Disease severity ascertained by CT and conventional angiography was well correlated

According to Michael Poon, M.D., associate professor of Medicine in Cardiology at Mount Sinai School of Medicine in New York and current president of the Society of Cardiovascular Computed Tomography (SCCT), he stated in an interview with Angioplasty.org that the [CORE 64] study “showed that, as a test to rule out the presence of significant coronary disease, CTA is capable of doing a rather good job. But at this moment it’s still not the test that you would use to compete with diagnostic angiography for accuracy. I think that’s the conclusion that we can draw from the CorE 64 data.”

Dr. Poon added, “We said that the accuracy of CT is very good when it comes to ruling out the presence of disease. We never said that CT is as accurate as diagnostic cath.”

For more information: www.content.nejm.org and www.angioplasty.org

Related Content

Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
NewYork-Presbyterian Expands Mobile Stroke Treatment Unit Fleet

Image courtesy of NewYork-Presbyterian Hospital

News | Stroke | June 11, 2018
NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the...
Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT. How to lower radiation dose from Computed tomography scanners using ned technology.

Latest additions to Somatom go. CT platform address advanced clinical fields and applications, including cardiology, CT-guided intervention and dual energy CT.

Feature | Computed Tomography (CT) | June 04, 2018 | By Melinda Taschetta-Millane
Recent studies show a rapid increase in patient radiation exposure mainly due to increased use of medical imaging, pa
Lung Decision Precision
News | Lung Cancer | June 04, 2018
For smokers and former smokers, the threat of lung cancer always lurks in the shadows.
American Cancer Society Updates Colorectal Cancer Screening Guideline
News | Colonoscopy Systems | May 30, 2018
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at...
Overlay Init